Market Research Logo

Respiratory Drugs Global Market Outlook 2018 Including: Respiratory Drugs, Anti-Asthmatics And COPD Drugs, Decongestants, Cough And Cold Preparations.Covering: GlaxosmithKline Plc., AstraZeneca Plc., Merck & Co., Novartis AG, Johnson & Johnson, Gilead, Ba

Respiratory Drugs Global Market Outlook 2018 Including: Respiratory Drugs, Anti-Asthmatics And COPD Drugs, Decongestants, Cough And Cold Preparations.Covering: GlaxosmithKline Plc., AstraZeneca Plc., Merck & Co., Novartis AG, Johnson & Johnson, Gilead, Bayer AG, Boehringer Ingelheim GmbH, Teva Pharmaceuticals, Pfizer Inc.

North America was the largest region in the respiratory diseases drugs market in 2017, accounting for around 48% market share. Asia Pacific was the second largest region accounting for around 19% market share. frica was the smallest region accounting for around 2% market share.

Respiratory Drugs Global Market Outlook 2018 provides strategists, marketers and senior management with the critical information they need to assess the global respiratory drugs sector.

Reasons to Purchase

  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Respiratory Drugs Global Market Outlook 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the respiratory drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the respiratory drugs market and suggests approaches.

Scope

Markets Covered: Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations.

Companies Mentioned: GlaxosmithKline Plc., AstraZeneca Plc., Merck & Co., Novartis AG, Johnson & Johnson, Gilead, Bayer AG, Boehringer Ingelheim GmbH, Teva Pharmaceuticals, Pfizer Inc.

Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Respiratory Drugs Market Characteristics
Respiratory Drugs Market Historic Growth (2013-17)
Respiratory Drugs Market Forecast Growth (2017-21)
Respiratory Drugs Market Segmentation
Global Respiratory Drugs Market, Split By Segments, 2017, $ Billion
Anti-Asthmatics And COPD Drugs
Cough And Cold Preparations
Global Respiratory Drugs Market, Historic and Forecast, Split By Segments, 2013-2021
Respiratory Drugs Market Geography Regional and Country Comparison
Global Respiratory Drugs Market, Split By Regions, 2017
Global Respiratory Drugs Market, Historic And Forecast Growth (2017-21) Rate, Split By Region, 2013-2021
Global Respiratory Drugs Market, Split By Country, 2017
Global Respiratory Drugs Market, Historic And Forecast Growth (2017-21) Rate, Split By Country, 2013-2021
Respiratory Drugs Market Competitive Landscape
GlaxosmithKline Plc.
AstraZeneca Plc.
Merck & Co.
Novartis AG
Johnson & Johnson
Gilead
Bayer AG
Boehringer Ingelheim GmbH
Teva Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
AstraZeneca PLC
Merck & Co.
Respiratory Drugs Market Key Mergers And Acquisitions
AstraZeneca Acquired Almirall’s Respiratory Business
Recordati Acquired Italchimici S.p.A.
Mast Therapeutics, Inc. Merged With Savara
Vectura Merged With Skyepharma
Ruthigen Merged With Pulmatrix
Ario Pharma Acquired PharmEste’s TRPA1 Research Assets
Respiratory Drugs Market Trends And Strategies
Growing Demand For Tamper-Resistant Pseudoephedrine (PSE) Products
Resurgence Of Nasal Remedies For Treatment Of Cold
Development Of RMC-1 Drug For Respiratory Diseases Treatment
Collaborations In The Respiratory Diseases Drugs Market
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report